A team led by UCL researchers with Great Ormond Street Hospital (GOSH) and Moorfields Eye Hospital, found B cells—alongside T cells—play a key role in arthritis-related eye disease (JIA uveitis), a ...

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all the secrets of life. “And so I conclude that blood lives and is nourished of itself and in no way ...

Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...

A new study published in the journal Nature reports results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors expressing glypican-3 (GPC3). Researchers ...

MADISON (WKOW) -- Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center for Cancer and Blood Disorders at Children's Wisconsin.

Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.